SUBSPECIALTY CLINIC
The goal of this rotation is to allow for a more diversified outpatient experience during residency. Since there are already dedicated blocks for Epilepsy and Neuromuscular, the focus of this rotation will be on Neuroimmunology, Neuro-Onc, and Movement Disorders.
There is lots of general helpful clinic information on the Continuity Clinic page - please also review before your rotation.
GENERAL DESCRIPTION OF THE ROTATION
Residents will rotate through the subspecialty faculty neurology clinics on the third floor of the Frenkil building at 16 S. Eutaw St. (or via Telemedicine). The rotation provides a diverse outpatient neurology experience. Since there are separate dedicated blocks for Epilepsy and Neuromuscular, the focus of this rotation will be on Neuroimmunology, Movement Disorders, and Neuro-Oncology.
Neuro-Oncology Logistics: Dr. Ahmad has clinic in the Stoler Cancer Pavilion (room varies depending on the day).
SCHEDULE
You will receive a weekly schedule from Andrea Reddick. If you do not, please email her.
08:00-11:30 Morning Session
11:30-12:30 Midday Didactics (12:30-1:30 on Wed)
12:30-5:00 Afternoon Session
Each week, the resident will be assigned:
6 Sessions: Subspecialty clinic
1 session continuity clinic
1 morning Scholarly time (meet with research mentor, work on IRB, analyze data, write, etc.)
1 morning Personal time (schedule your own doctor, dentist, car repair, etc.).
Wed Afternoons: Grand Rounds & Case Conference
EVALUATIONS
Ask Penelope Birckhead to send the evaluation for this rotation through MedHub to whichever attending you worked with the most.
This rotation is a great time to get some of your Clinical Skills Exam requirements for ABPN board eligibility completed. More information on the CSE requirements: https://marylandneurology.squarespace.com/abpn-clinical-skills-evaluation.
COMPETENCY-BASED GOALS AND OBJECTIVES
SUBSPECIALTY - SPECIFIC MEDICAL KNOWLEDGE GOALS & OBJECTIVES
NEURO-IMMUNOLOGY / MULTIPLE SCLEROSIS
Immunological and pathological features of the MS
MS risk factors: Genetic, Environmental
Approaches to MS diagnosis, including
The use of MRI in diagnosis
The application of the McDonald Criteria
Identify diseases that mimic MS and discuss approaches to ruling out these diagnoses
Clinical features of MS subtypes
Treatment and management of MS, including:
The MS disease-modifying therapies
Identify MS treatment failure and decision-making related to switching therapy
Evaluation of MS-related disability and MS symptom management
Discuss differential diagnosis of demyelinating and other inflammatory CNS disorders
MOVEMENT DISORDERS
Clinically classify abnormal movements by phenomenology: parkinsonism, chorea, tremor, dystonia, tics, ataxia, myoclonus and others.
Construct a differential diagnosis for patients with each of the broad categories of movement disorders
Formulate a diagnostic strategy for patients with movement disorders.
Describe non-motor components of movement disorders including behavioral, cognitive, autonomic and other features.
Describe basic principles of neuroanatomy, neuropathology and neuropharmacology as they pertain to Movement Disorders.
List side effects of common Movement Disorder therapies.
Describe the indications for botulinum toxin injection therapy
Perform basic interpretation of common neurologic imaging studies of the brain and spine (MRI and CT) in patients with Movement Disorders.
KEY READINGs
NEUROIMMUNOLOGY AND MS
AAN Practice Parameters
Disease modifying therapies: https://www.aan.com/Guidelines/home/GuidelineDetail/898
Rehabilitation in MS: https://www.aan.com/Guidelines/home/GuidelineDetail/720
Assessment and management of psychiatric disorders in MS: https://www.aan.com/Guidelines/home/GuidelineDetail/628
Complementary and Alternative Medicine: https://www.aan.com/Guidelines/home/GuidelineDetail/641
Others:
Chapter on Multiple Sclerosis in Merrittโs textbook
CONTINUUM: Multiple Sclerosis and Other Demyelinating Diseases.
Reich DS, et al. Multiple Sclerosis. NEJM. 2018 Jan 11;378(2):169-180. [PMID: 29320652]
MOVEMENT DISORDERS
AAN Practice Parameters
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache
Evidence-based guideline: Treatment of tardive syndromes
Evidence-based guideline update: Treatment of essential tremor
Continuum โ Movement Disorders August 2019 (or most recent version if/when updated)
NEURO-ONCOLOGY
NeuroOncology Continuum page, which will show you the most recent issue.
Last Updated: June 20, 2023